The Pfizer vaccine protects against COVID-19. It protects you from severe infection, hospitalisation and death. Find out about the vaccine and possible side effects.
On this page, you can find the following information:
- Who can get the Pfizer vaccine?
- How does the Pfizer vaccine work?
- How safe is the Pfizer vaccine?
- Who should not be vaccinated with the Pfizer vaccine?
- Can I have the Pfizer vaccine if I am pregnant?
- Can I have the Pfizer vaccine if I am breastfeeding?
- Can the COVID vaccine affect fertility?
- Should I get a vaccine if I have already had COVID?
- How is the Pfizer vaccine given?
- How many doses of the Pfizer vaccine do you need?
- Can the Pfizer vaccine be given with other vaccines?
- What are the common side effects of the Pfizer vaccine?
- Is there a risk of allergic reaction with the Pfizer vaccine?
- Is there a risk of myocarditis with the Pfizer vaccine?
- Is there a risk of blood clots with bleeding with the Pfizer vaccine?
- Does the Pfizer vaccine cause unexpected vaginal bleeding or period problems?
Everyone in Aotearoa New Zealand aged 5 years and over can book their free COVID-19 vaccination now. It doesn’t matter what your visa or citizenship status is.
Tamariki aged 5–11 will receive the children’s (paediatric) version of the Pfizer vaccine, with a lower dose and smaller volume. It is also given using a smaller needle. Read more about Pfizer COVID-19 vaccine in children 5 years old and over.
The Pfizer vaccine is a highly effective vaccine for preventing you getting the coronavirus disease COVID-19, which is caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2).
The Pfizer vaccine protects against COVID-19. The vaccine stimulates your body’s immune system to produce antibodies to help fight the virus that causes COVID-19.
Vaccination means that if you do become infected you are far less likely to become seriously ill or spread the virus to others.
None of the ingredients in this vaccine can cause COVID-19.
The Pfizer vaccine is safe. Before vaccines are provided to the community, they must be approved by Medsafe, the New Zealand Medicines and Medical Devices Safety Authority. Medsafe only grants consent for a vaccine to be used in New Zealand once they are satisfied it’s safe and effective enough to use. It has given provisional approval for the use of the Pfizer vaccine, the same kind of approval given to the annual flu vaccine.
Medsafe is monitoring the safety of the vaccine as it is rolled out around the country. You can read Medsafe’s latest safety reports on the vaccine here: Overview of vaccine reports.
The Pfizer vaccine has an excellent safety profile and there are only a handful of people in Aotearoa who cannot receive it.
- It is currently not licensed for use in children under 5 years of age.
- If you are currently isolating or experiencing symptoms of COVID-19, you should not be vaccinated until you have recovered and have met the criteria to stop isolating.
- If you have had a previous severe allergic reaction (anaphylaxis) to an ingredient of the vaccine. This is very rare, and only applies to previous anaphylaxis to a stabiliser in the vaccine called polyethylene glycol (PEG). However, this is often unclear as problems with PEG most commonly occur after having it by mouth and there may not be any problem with having it in a vaccine. This will be assessed by an immunology specialist.
- If you have had a severe allergic reaction (anaphylaxis) usually within 15 minutes after the first dose. Increasing experience now shows that many people can be revaccinated safely in a specialist immunology clinic setting.
- If you have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the lining around the heart) after your first dose. Myocarditis or pericarditis after the vaccine is rare. Diagnosis requires special tests and often assessment by a heart specialist.
Learn more about who can't have the Pfizer/BioNTech COVID-19 vaccine.
People with other allergies
- Some people develop delayed allergic type symptoms to the vaccine, such as hives and other skin rashes. These people can safely get their second dose (see delayed allergic symptoms below).
- People with a history of allergy to foods and venom can be vaccinated.
- People with a history of severe immediate allergic response (anaphylaxis) to another vaccine or multiple medicines can receive this vaccine but are asked to wait to be observed for a little longer after vaccination.
You are strongly encouraged to be vaccinated against COVID-19 at any stage of pregnancy. A Medsafe review of the use of the Pfizer vaccine in pregnancy found no safety concerns (Safety of the Comirnaty (Pfizer COVID-19) vaccine during pregnancy.) Read more about COVID-19 and pregnancy.
You can get the Pfizer vaccine if you are breastfeeding. There are no safety concerns about giving the Pfizer vaccine to people who are breastfeeding. By being vaccinated, you can provide some protection against COVID-19 for your baby through your breastmilk. Read more about the use of the Pfizer vaccine in pregnancy and breastfeeding.
No, the Pfizer vaccine will not affect your genes or fertility. The mRNA from the vaccine does not enter the nucleus of any cells, which is where your DNA is. Read more about Comirnaty and fertility.
Yes, you should start, or continue, with your vaccinations 12 weeks (3 months) after you have recovered from COVID-19. Being vaccinated provides better protection than any immunity you might get from being infected with the virus and can also help protect you from new variants of COVID-19.
The Pfizer vaccine is given as an injection into the muscle of your upper arm by a trained healthcare professional.
After your vaccination
A trained healthcare professional will keep an eye on you for at least 15 minutes after being given the Pfizer vaccine to make sure you don't have any reaction to the vaccination. Read more about getting your vaccination and what to expect.
The number of doses you need and the gap between the doses will depend on whether you are getting your primary vaccine series or your booster doses and whether you have a weakened immune system or not. Read more about the recommended timing gaps for different COVID-19 vaccines.
All vaccines (except the shingles vaccine) can be given at the same time or immediately before or after the COVID-19 vaccine. Read more about the COVID vaccine and other vaccines.
Like all vaccines, the Pfizer vaccine can cause side effects, although not everyone gets them. They are more commonly reported after a second dose and in younger adults (aged under 55 years). Read more: After your vaccination.
|Side effects||What should I do?|
|Did you know that you can report a side effect to a medicine to CARM (Centre for Adverse Reactions Monitoring)? Report a side effect to a product.|
Serious allergic reactions can occur but they are extremely rare. New Zealand vaccinators are trained to manage these. Most people with a history of anaphylaxis to other medicines, vaccines, foods and venom can be safely vaccinated.
Signs of an allergic reaction include skin rash, itching, swelling of your lips, face and mouth, or difficulty breathing.
- A trained healthcare professional will observe you for at least 15 minutes after being given the Pfizer vaccine
- If these symptoms develop after that, go straight to the emergency department at your nearest hospital, or call 111 if your hospital is not nearby.
Some people develop delayed allergic symptoms such as swelling around your eyes or face, hives or a rash. This can develop from a few hours to days after getting your vaccine. The symptoms may settle on their own without treatment or you can use antihistamine tablets (eg, cetirizine or loratadine). Tell your doctor if you are concerned.
Most people who develop delayed allergic symptoms with the first dose can safely get the second dose. You can take an antihistamine (eg, cetirizine or loratadine) prior to or following the second dose. Most people will have a similar milder reaction with the second dose.
There have been very rare reports of myocarditis, pericarditis or both (myopericarditis) occurring after vaccination with the Comirnaty Pfizer COVID-19 vaccine. Note that infection by COVID-19 is far more likely to cause myocarditis than vaccination.
Myocarditis is inflammation affecting the heart muscle. Pericarditis is inflammation of the lining around the heart. Myopericarditis is a mixture of myocarditis and pericarditis.
What we know so far:
A Medsafe and CARM (Centre for Adverse Reactions Monitoring) review of the reports of myocarditis and pericarditis received to date has found that:
- Symptoms usually appear within 1–5 days after receiving the Pfizer vaccine.
- Pericarditis is observed in a range of age groups.
- Myocarditis occurs particularly in males under 30 years of age after the second vaccine dose. Even in this group, risk has been reported internationally to be from 1 to 10 per 100,000 vaccine doses.
- There is increasing evidence that the rate declines as the interval between doses increases up to 8 weeks and the risk following booster doses is lower than after the second dose.
- Most cases of myocarditis following Pfizer COVID-19 vaccination are mild and resolve within a short time with standard treatment and rest.
- For advice about receiving further doses of COVID vaccinations, speak to your doctor.
|Seek medical attention if you experience any of the following in the first few days after your vaccination:
For the latest reports on adverse events following immunisation with COVID-19 vaccines, see overview of vaccine reports.
Medsafe has completed a review of the risk of rare cases of blood clots with bleeding reported internationally with some COVID-19 vaccines. To date, all the cases that have been reported after vaccination are linked to the first dose of Vaxzevria (AstraZeneca) or the Janssen COVID-19 vaccines. These vaccines are not currently used in New Zealand. Medsafe continues to monitor this safety signal and remains in contact with international regulators. Read more about COVID-19 vaccines and blood clots.
No, there is no evidence to suggest a link between vaccination with the Pfizer vaccine and unexpected vaginal bleeding or period problems (menstrual disorders). A full review by Medsafe of all reports of menstrual disorders or unexpected vaginal bleeding following vaccination, as well as the international published literature, and post-marketing safety reports provided by the Sponsor (Pfizer) did not find any link to the vaccine.
Menstrual disorders and unexpected vaginal bleeding occur commonly in the population, regardless of vaccination, and there are many possible underlying causes, including anxiety caused by the ongoing pandemic. Any changes occurring after COVID-19 vaccination are likely to be temporary, and there is no evidence that these temporary changes will affect future fertility. Read more about menstrual disorders and Comirnaty.
For other reliable and accurate information about COVID-19 vaccines, see:
Getting vaccinated for COVID-19 The Immunisation Advisory Centre, NZ
Update around management of those with allergic reaction to their first dose of Comirnaty or history of PEG allergy The Immunisation Advisory Centre, NZ
- Comirnaty COVID-19 vaccine Medsafe Consumer Information, NZ
- Comirnaty European Medicines Agency
- Time between doses of COVID-19 vaccine extended Unite against Covid-19, NZ, 2021
- Myocarditis and the mRNA COVID-19 vaccine in New Zealand - information for health professionals The Immunisation Advisory Centre, NZ
- Myocarditis and the mRNA COVID-19 vaccine in New Zealand IMAC May 2022
Additional resources for healthcare professionals
COVID-19 education The Immunisation Advisory Centre, NZ
How the Comirnaty (Pfizer/BioNTech) vaccine works and how we assess its safety The Immunisation Advisory Centre, NZ, 2021